DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-80,275

PFIZER THERAPEUTIC RESEARCH
FORMERLY KNOWN AS WARNER LAMBERT COMPANY
PFIZER WORLDWIDE RESEARCH & DEVELOPMENT DIVISION
ANTIBACTERIALS RESEARCH UNIT
PHARMACOKINETICS, DYNAMICS AND METABOLISM DEPARTMENT
ANTIBACTERIAL CHEMISTRY DEPARTMENT
ANALYTICAL CHEMISTRY AND MATERIAL MANAGEMENT DEPARTMENT GROTON,
CONNECTICUT

Amended Certification Regarding Eligibility to
Apply for Worker Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended (“Act”), 19 U.S.C. § 2273, the Department of Labor
(Department) issued a Revised Determination of Reconsideration of
Eligibility to Apply for Worker Adjustment Assistance on December
2, 2011, applicable to workers of Pfizer Therapeutic Research,
Pfizer Worldwide Research & Development Division, Antibacterial
Research Unit, Groton, Connecticut (Pfizer-ARU).
At the request of the state workforce office, the Department
reviewed the certification for workers of Pfizer-ARU.
The Department has determined that other units at the
Groton, Connecticut facility operate in conjunction with Pfizer-
ARU and have experienced worker separations related to the shift
in the supply of services to a foreign country.
In order to ensure proper worker group coverage, the
Department is amending the worker group identified in the
certification for TA-W-80,275 to include the Pharmacokinetics,
Dynamics and Metabolism Department, Antibacterial Chemistry
Department, and Analytical Chemistry and Material Management
Department located in Groton, Connecticut.
The amended notice applicable to TA-W-80,275 is hereby
issued as follows:
“All workers of Pfizer Therapeutic Research, formerly known
as Warner Lambert Company, Pfizer Worldwide Research &
Development Division, Antibacterial Research Unit,
Pharmacokinetics, Dynamics and Metabolism Department,
Antibacterial Chemistry Department, and Analytical Chemistry
and Material Management Department, Groton, Connecticut, who
became totally or partially separated from employment on or
after July 8, 2010 through December 2, 2013, and all workers
in the group threatened with total or partial separation
from employment on the date of certification through two
years from the date of certification, are eligible to apply
for adjustment assistance under Chapter 2 of Title II of the
Trade Act of 1974, as amended.”
Signed in Washington, D.C., this 25th day of May, 2012
/s/ Del Min Amy Chen
______________________________
DEL MIN AMY CHEN
Certifying Officer, Office of
Trade Adjustment Assistance
4510-FN-P


DEPARTMENT OF LABOR

Employment and Training Administration

TA-W-80,275

PFIZER THERAPEUTIC RESEARCH
PFIZER WORLDWIDE RESEARCH & DEVELOPMENT DIVISION
ANTIBACTERIALS RESEARCH UNIT
FORMERLY KNOWN AS WARNER LAMBERT COMPANY
GROTON, CONNECTICUT

Negative Determinations Regarding Eligibility
To Apply for Worker Adjustment Assistance
And Alternative Trade Adjustment Assistance

In accordance with Section 223 of the Trade Act of 1974, as
amended (“Act”), 19 U.S.C. § 2273, the Department of Labor herein
presents the results of an investigation regarding certification
of eligibility to apply for worker adjustment assistance.
Workers of a firm may be eligible for worker adjustment
assistance if they satisfy the criteria of subsection (a) and
(b) of Section 222 of the Act, 19 U.S.C. § 2272(a) and (b). For
the Department of Labor to issue a certification for workers
under Section 222(a) of the Act, 19 U.S.C. § 2272(a), the
following three criteria must be met:
(1) The first criterion (set forth in Section 222(a)(1) of the
Act, 19 U.S.C. § 2272(a)(1)) requires that a significant
number or proportion of the workers in such workers' firm,
or an appropriate subdivision of the firm, have become
totally or partially separated, or are threatened to become
totally or partially separated
(2) The second criterion (set forth in Section 222(a)(2) of the
Act, 19 U.S.C. § 2272(a)(2)) may be satisfied in one of two
ways:
(A) Increased Imports Path:
(i) sales or production, or both, at the workers’ firm must
have decreased absolutely, AND
(ii) imports of articles like or directly competitive with
articles produced by such firm or subdivision have
increased; and
(iii) the increase described in clause (ii) contributed
importantly to such workers’ separation or threat of
separation and to the decline in the sales or
production of such firm or subdivision.

(B) Shift in Production Path:
(i) there has been a shift in production by such workers’
firm or subdivision to a foreign country of articles
like or directly competitive with articles which are
produced by such firm or subdivision; and
(ii)(I) the country to which the workers’ firm has
shifted production of the articles is a party to a free
trade agreement with the United States;
(II)the country to which the workers’ firm has
shifted production of the articles is a beneficiary
country under the Andean Trade Preference Act, African
Growth and Opportunity Act, or the Caribbean Basin
Economic Recovery Act; or
(III)there has been or is likely to be an increase
in imports of articles that are like or directly
competitive with articles which are or were produced by
such firm or subdivision.

For the Department to issue a secondary worker certification
under Section 222(b) of the Act, 19 U.S.C. § 2272(b), to workers
of a Supplier or a Downstream Producer, the following criteria
must be met:
(1) a significant number or proportion of the workers in
the workers’ firm or an appropriate subdivision of the
firm have become totally or partially separated, or are
threatened to become totally or partially separated;

(2) the workers’ firm is a Supplier or Downstream Producer
to a firm that employed a group of workers who received
a certification of eligibility under Section 222(a) of
the Act, 19 U.S.C. § 2272(a), and such supply or
production is related to the article that was the basis
for such certification; and

(3) either
(A) the workers’ firm is a supplier and the component parts
it supplied to the firm described in paragraph (2)
accounted for at least 20 percent of the production or
sales of the workers’ firm; or
(B) a loss of business by the workers’ firm with the firm
described in paragraph (2) contributed importantly to
the workers’ separation or threat of separation.

Section 222(c) of the Act, 19 U.S.C. § 2272(c), defines the
terms “Supplier” and “Downstream Producer.”
The investigation was initiated in response to a petition
filed on July 11, 2011 by a Connecticut state workforce official
on behalf of workers of Pfizer Therapeutic Research, Pfizer
Worldwide Research & Development Division, Antibacterials
Research Unit, formerly known as Warner Lambert Company, Groton,
Connecticut. The workers’ firm is engaged in activities related
to the production of pharmaceuticals. The worker group is
engaged in antibacterial research and development services.
The petitioner alleges that the subject firm is shifting the
Antibacterials Research Unit to a foreign country. During the
course of the investigation, information was collected from the
workers’ firm.
With respect to Section 222(a)(2)(B) of the Act, the
investigation revealed that the worker separations are not
attributable to a shift in production of articles by the firm to
a foreign country. Rather, the investigation confirmed that the
worker separations are attributable to a shift of services by the
firm to a foreign country.
With respect to Section 222(a)(2)(A)(iii), the investigation
revealed that the worker separations are not attributable to
increased imports of articles like or directly competitive with
articles produced by the firm.
With respect to Section 222(b), the investigation revealed
that Pfizer Therapeutic Research is not a Supplier or Downstream
Producer to a firm that employed a group of workers who received
a certification of eligibility under Section 222(a) of the Act,
19 U.S.C. § 2272(a).
In order for the Department to issue a certification of
eligibility to apply for alternative trade adjustment assistance
(ATAA), the worker group must be certified eligible to apply for
trade adjustment assistance (TAA). Since the workers are denied
eligibility to apply for TAA, the workers cannot be certified
eligible for ATAA.
?
Conclusion
After careful review of the facts obtained in the
investigation, I determine that all workers of Pfizer Therapeutic
Research, Pfizer Worldwide Research & Development Division,
Antibacterials Research Unit, formerly known as Warner Lambert
Company, Groton, Connecticut are denied eligibility to apply for
adjustment assistance under Section 223 of the Trade Act of 1974,
as amended, and are also denied eligibility to apply for
alternative trade adjustment assistance under Section 246 of the
Trade Act of 1974, amended.
Signed in Washington, D.C. this 28th day of September 2011


/s/Michael W. Jaffe
______________________________
MICHAEL W. JAFFE
Certifying Officer, Office of
Trade Adjustment Assistance





- 2 -